Influence of HIV infection and the use of antiretroviral therapy on selenium and selenomethionine concentrations and antioxidant protection

Nutrition

Volumn 32, Issue 11-12, 2016, Pages 1238-1242

  Watanabe, Lígia Moriguchi ^a   Barbosa Júnior, Fernando ^b   Jordão, Alceu Afonso ^b   Navarro, Anderson Marliere ^b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antiretroviral therapy; HIV; Oxidative stress; Selenium; Selenomethinine

Indexed keywords

ANTIRETROVIRUS AGENT; GLUTATHIONE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; SELENIUM; SELENOMETHIONINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIOXIDANT;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIETARY INTAKE; DRUG USE; ENZYME ACTIVITY; ERYTHROCYTE LEVEL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OXIDATIVE STRESS; PROSPECTIVE STUDY; SELENIUM BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; DRUG EFFECTS; HIV INFECTIONS; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADULT; ANTI-HIV AGENTS; ANTIOXIDANTS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HIV INFECTIONS; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; PROSPECTIVE STUDIES; SELENIUM; SELENOMETHIONINE; YOUNG ADULT;

EID: 84975247445     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2016.03.024     Document Type: Article

References (28)

1. [1] Zhao, L., Cox, A.G., Ruzicka, J.A., Bhat, A.A., Zhang, W., Taylor, E.W., Molecular modeling and in vitro activity of an HIV-1-encoded glutathione peroxidase. Proc Natl Acad Sci U S A 97 (2000), 6356–6361.
2. [2] Stephensen, C.B., Marquis, G.S., Douglas, S.D., Wilson, C.M., Immune activation and oxidative damage in HIV-positive and HIV-negative adolescents. J Acquir Immune Defic Syndr 38 (2005), 180–190.
3. [3] Steinbrenner, H., Al-Quraishy, S., Dkhil, M.A., Wunderlich, F., Helmut, S., Dietary selenium in adjuvant therapy of viral and bacterial infections. Adv Nutr 6 (2015), 73–82.
4. [4] Porter, K.M., Sutliff, R.L., HIV-1, reactive oxygen species, and vascular complications. Free Radic Biol Med 53 (2012), 143–159.
5. [5] Deeks, S.G., Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy. Top HIV Med 17 (2009), 118–123.
6. [6] Libman, H., Beth Israel Deaconess Medical Center Healthcare Associates HIV Manual. 2014 Available at: http://aidsetc.org/resource/hiv-manual Accessed April 18, 2016.
7. [7] Stephensen, C.B., Marquis, G.S., Douglas, S.D., Kruzich, L.A., Wilson, C.M., Glutathione, glutathione peroxidase, and selenium status in HIV-positive and HIV-negative adolescents and young adults. Am J Clin Nutr 85 (2007), 173–181.
8. [8] Hoffmann, P.R., Berry, M.J., The influence of selenium on immune responses. Mol Nutr Food Res 52 (2008), 1273–1280.
9. [9] Pedrero, Z., Madrid, Y., Novel approaches for selenium speciation in foodstuffs and biological specimens: a review. Anal Chim Acta 634 (2009), 135–152.
10. [10] Ogra, Y., Anan, Y., Selenometabolomics explored by speciation. Biol Pharm Bull 35 (2012), 1863–1869.
11. [11] Institute of Medicine (IOM), Food and Nutrition Board. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. Washington, DC: National Academy Press.
12. [12] Brazil Ministério da saúde. Boletim Epidemiológico AIDS-DST, ano II n.1. 2013 Available at: www.aids.gov.br/sites/default/files/anexps/publicacao/2013/55559/_p_boletim_2013_internet_pdf_p51315.pdf Accessed April 18, 2016.
13. [13] CDC—Centers for Disease Control and Prevetion. HIV classification: CDC and WHO Staging Systems. 2012 Available at: http://www.aidsetc.org/aidsetc?page=cg-205_hiv_classification Accessed April 18, 2016.
14. [14] Gerard-Monnier, D., Erdelmeier, I., Regnard, K., Moze-Henry, N., Yadan, J.C., Chaudiere, J., Reactions of 1-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals. Analytical applications to a colorimetric assay of lipid peroxidation. Chem Res Toxicol 11 (1998), 1176–1183.
15. [15] Costa, C.M., Santos, R.C., Lima, E.S., A simple automated procedure for thiol measurement in human serum samples. J Bras Patol Med Lab 42 (2006), 345–350.
16. [16] Paglia, D.E., Valentine, W.N., Studies on the quantitative and qualitative characterization of erythrocite glutathione peroxidase. J Lab Clin Med 70 (1967), 159–169.
17. [17] Batista, B.L., Rodrigues, J.L., Nunes, J.A., Souza, V.C., Barbosa-Júnior, F., Exploiting dynamic reaction cell inductively coupled plasma mass spectrometry (DRC-ICP-MS) for sequential determination of trace elements in blood using a dilute-and-shoot procedure. Anal Chim Acta 639 (2009), 13–18.
18. [18] Nyman, D.W., Stratton, M.S., Kopplin, M.J., Dalkin, B.L., Nagle, R.B., Gandolfi, A.J., Selenium and selenomethionine levels in prostate cancer patients. Cancer Detect Prev 28 (2004), 8–16.
19. [19] de Menezes Barbosa, E.G., Júnior, F.B., Machado, A.A., Navarro, A.M., A longer time of exposure to antiretroviral therapy improves selenium levels. Clin Nutr 34 (2015), 248–251.
20. [20] Hileman, C.O., Dirajlal-Fargo, S., Lam, S.K., Kumar, J., Lacher, C., Combs, G.F. Jr., et al. Plasma selenium concentrations are sufficient and associated with protease inhibitor use in treated HIV-infected adults. J Nutr 145 (2015), 2293–2299.
21. [21] Combs-Júnior, G.F., Watts, J.C., Jackson, M.I., Determinants of selenium status in healthy adults. Nutrition, 75, 2011, 10.
22. [22] Look, M.P., Rockstroh, J.K., Rao, G.S., Kreuzer, K.A., Barton, S., Lemoch, H., et al. Serum selenium, plasma glutathione (GSH) and erythrocyte glutathione peroxidase (GSH-Px) levels in asymptomatic versus sympomatic human immunodeficiency virus-1 (HIV-1) infection. Eur J Clin Nutr 51 (1997), 266–272.
23. [23] De Rosa, S.C., Zaretsky, M.D., Dubs, J.G., Roederer, M., Anderson, M., Green, A., et al. N-acetylcysteine replenishes glutathione in HIV infection. Eur J Clin Invest 30 (2000), 915–929.
24. [24] Gil, L., Martinez, G., Gonzalez, I., Tarinas, A., Alvarez, A., Guiliani, A., et al. Contribution to characterization of oxidative stress in HIV/AIDS patients. Pharmacol Res 47 (2003), 217–224.
25. [25] Teto, G., Kanmogne, G.D., Torimiro, J.N., Alemnji, G., Nguemaim, F.N., Takou, D., et al. Lipid peroxidation and total cholesterol in HAART-naïve patients infected with circulating recombinant forms of human immunodeficiency virus type-1 in Cameroon. PLos One, 8, 2013, e65126.
26. [26] Ogunro, P.S., Ogungbamigbe, T.O., Elemie, P.O., Egbewale, B.E., Adewole, T.A., Plasma selenium concentration and glutathione peroxidase activity in HIV-1/AIDS infected patients: a correlation with the disease progression. Niger Postgrad Med J 13 (2006), 1–5.
27. [27] Velazquez, I., Plaud, M., Wojna, V., Skolasky, R., Laspiur, J.P., Melendez, L.M., Antioxidant enzyme dysfunction in monocytes and CSF of Hispanic women with HIV-associated cognitive impairment. J Neuroimmunol 206 (2009), 106–111.
28. [28] Labunskyy, V.M., Hatfield, D.L., Gladyshev, V.N., Selenoproteins: molecular pathways and physiological roles. Physiol Rev 94 (2014), 739–777.